Evidence map›Paper›PMID 30135731›Full record

ArticleF1000Research2018

Ten considerations for open peer review.

Birgit Schmidt, Tony Ross-Hellauer, Xenia van Edig, Elizabeth C Moylan

Abstract read
In one paragraph

Article in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. JID innovations : skin science from molecules to population health · 2021
    Article
  5. Should we open the reviewing process.Food technology and biotechnology · 2021
    Article
  6. Peer Review in Law Journals.Frontiers in research metrics and analytics · 2021
    Article
  7. Innovative Strategies for Peer Review.Journal of Korean medical science · 2020
    Article
  8. Preprints in Medicine: Useful or Harmful?Frontiers in medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Birgit SchmidtState and University Library, University of Göttingen, Göttingen, 37070, Germany.ORCID 0000-0001-8036-5859
Tony Ross-HellauerKnow-Center GmbH, Graz, 8010, Austria.
Xenia van EdigCopernicus Publications, Göttingen, 37081, Germany.ORCID 0000-0003-2510-0529
Elizabeth C MoylanBioMed Central, London, N1 9XW, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Open peer review (OPR), as with other elements of open science and open research, is on the rise. It aims to bring greater transparency and participation to formal and informal peer review processes. But what is meant by `open peer review', and what advantages and disadvantages does it have over standard forms of review? How do authors or reviewers approach OPR? And what pitfalls and opportunities should you look out for? Here, we propose ten considerations for OPR, drawing on discussions with authors, reviewers, editors, publishers and librarians, and provide a pragmatic, hands-on introduction to these issues. We cover basic principles and summarise best practices, indicating how to use OPR to achieve best value and mutual benefits for all stakeholders and the wider research community.

Indexed as

AuthorshipEditorial PoliciesPeer Review, ResearchHumansgood practiceopen peer reviewopen scienceresearch integrity

Identifiers

PMID30135731
PMCPMC6073088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.